AKBA vs REGN: Which Stock is Better?
Side-by-side comparison of Akebia Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
AKBA
Akebia Therapeutics Inc
$1.55
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | AKBA | REGN | Winner |
|---|---|---|---|
| Market Cap | $417.89M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.2% | 0.0% | AKBA |
| Gross Margin | 82.9% | 44.6% | AKBA |
Analyze AKBA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKBA or REGN a better investment?
Comparing AKBA and REGN: Akebia Therapeutics Inc has a market cap of $417.89M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKBA and REGN?
AKBA (Akebia Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKBA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKBA or REGN?
AKBA has higher revenue growth at 0.2% vs 0.0% for REGN.
Which company is more profitable: AKBA or REGN?
Akebia Therapeutics Inc (AKBA) has higher gross margins at 82.9% compared to 44.6% for REGN.
Which is the larger company: AKBA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $417.89M for AKBA.
Should I buy AKBA or REGN in 2026?
Both AKBA and REGN have investment merit. AKBA trades at $1.55 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKBA and REGN stock?
Key differences: Market Cap ($417.89M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.2% vs 0.0%), Gross Margin (82.9% vs 44.6%).